Hersh Kozlov - 01 Jul 2022 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Jul 2022, 16:13:54 UTC
Prior SEC filing
26 May 2022
Next SEC filing
26 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Richard S. Nelson as Attorney-in-Fact

Key filing fact

Hersh Kozlov filed Form 4 for vTv Therapeutics Inc. (VTVT) on 06 Jul 2022.

Key facts

  • This page summarizes Hersh Kozlov's Form 4 filing for vTv Therapeutics Inc. (VTVT).
  • 1 reported transaction and 3 derivative rows are listed below.
  • Accepted by SEC: 06 Jul 2022, 16:13.

Change

  • Previous filing in this sequence was filed on 26 May 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTVT transaction Derivative

Director stock option (right to buy)

Award

Transaction value
$0
Shares
+105,128
Change %
Price
$0.000000
Shares after
105,128
Date
01 Jul 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
105,128
Exercise price
$0.7200
Footnotes
F1
VTVT holding Derivative

Director stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
26,250
Date
01 Jul 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
26,250
Exercise price
$2.65
Footnotes
F2, F3
VTVT holding Derivative

Director stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,000
Date
01 Jul 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
15,000
Exercise price
$2.54
Footnotes
F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

An option to purchase 80,128 shares vested immediately on July 1, 2022. The remaining option to purchase 25,000 shares vests on June 1, 2023.

Footnote F2

On June 15, 2020 and May 5, 2021, the reporting person filed Form 4s which inadvertently aggregated options to purchase shares of Class A common stock with different exercise prices and expiration dates. These errors have been corrected in the options beneficially owned in this Form 4.

Footnote F3

An option to purchase 2,812 shares vested immediately on June 11, 2020. The remaining option to purchase 23,438 shares vests in equal monthly installments over the three-year period beginning on June 11, 2020.

Footnote F4

Vests in equal monthly installments over the three-year period beginning May 3, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .